$266.92
0.6%
Price vs. AI Score (Last 150 days)
Data gathered: November 29
Data gathered: November 29
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 599 -0.2% |
|
| Sentiment | 96 0% |
|
| Webpage traffic | 316,000 18.4% |
|
| Employee Rating | 83 0% |
|
| Google Adspend | $ N/A | N/A |
| Google Trends | 33 -50.7% |
|
| Linkedin Employees | 31,915 N/A |
|
| Lobbying Cost | $1,130,000 0% |
|
| Patents | 1,037 0.4% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 75 -7.4% |
|
| Facebook followers | 31,757 0% |
|
| Stocktwits Mentions | 4 -20% |
|
| Stocktwits Subscribers | 12,959 0% |
|
| Twitter Followers | 122,897 0% |
|
| Youtube Subscribers | 32,100 0% |
|
| Instagram Followers | 22,970 0% |
|
| News Mentions | 1 0% |
|
| Reddit Mentions | 0% |
|
| ESG | 76 0% |
|
| Business outlook | 74 0% |
|
In the news
AWS expands big pharma partnerships in manufacturing, AI, and R&DNovember 28 - Yahoo |
|
 |
This Stock Hasn't Split Since 1999 — $1,000 Invested Then Would Be Worth A Boatload TodayNovember 27 - Yahoo |
 |
Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET studyNovember 27 - The BMJ |
 |
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?November 27 - Yahoo |
 |
1 Spectacular Dividend Stock Every Investor Should ConsiderNovember 27 - Yahoo |
Amgen (NASDAQ:AMGN) Gains on New AWS PartnershipNovember 27 - TipRanks |
|
About Amgen
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
| Price | $266.92 |
| Target Price | Sign up |
| Market Cap | $142B |
| Dividend Yield | 0.0321 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 6.33B | 3.88B | 2.44B | 1.73B | 3.4B |
| Q2 '23 | 6.35B | 3.84B | 2.51B | 1.38B | 3.06B |
| Q1 '23 | 5.68B | 3.67B | 2B | 2.84B | 4.68B |
| Q4 '22 | 78M | 4.02B | 78M | 1.62B | 2.86B |
| Q3 '22 | 6.36B | 3.5B | 2.86B | 2.14B | 3.39B |
Insider Transactions
| Graham Jonathan P filed to sell 28,078 shares at $272.8. November 13 '23 |
| Gordon Murdo filed to sell 44,308 shares at $262.4. August 11 '23 |
| Khosla Rachna filed to sell 6,630 shares at $292.9. November 10 '22 |
| Grygiel Nancy A. filed to sell 13,009 shares at $293.5. November 8 '22 |
| Williams R Sanders filed to sell 5,301 shares at $250. August 22 '22 |
Read more about Amgen and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, lobbying cost, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, esg, business outlook.